More NewsRead More
pSivida Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs
September 28, 2015
pSivida Announces Top-Line Results from Investigator-Sponsored Phase II Study of Medidur™ for Uveitis to Be Reported Next Week
July 07, 2015
pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis
May 19, 2015
pSivida Announces Two Tech Evaluation Agreements with Leading Global Pharmaceutical Company
May 12, 2015
Benzinga's Top Initiations
October 15, 2015
pSivida Corp. Announces Third Quarter Fiscal Year 2015 Financial Results Release Date and Conference Call Information
May 01, 2015
pSivida Corp. Reports ILUVIEN® for DME Approved in Poland
April 14, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here